Výsledky vyhledávání

Akademický článek

CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma.

Autor: Balakrishnan PB; GW Cancer Center, Department of Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Ledezma DK; The Institute for Biomedical Sciences, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Cano-Mejia J; GW Cancer Center, Department of Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Andricovich J; The Institute for Biomedical Sciences, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Palmer E; GW Cancer Center, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Patel VA; Department of Dermatology & Oncology, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Latham PS; Department of Pathology, School of Medicine and Health Sciences, George Washington University, Washington, DC 20037, USA., Yvon ES; GW Cancer Center, Department of Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Villagra A; GW Cancer Center, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA., Fernandes R; GW Cancer Center, Department of Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA.; The Institute for Biomedical Sciences, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA.; ImmunoBlue, Bethesda, MD 20817, USA., Sweeney EE; GW Cancer Center, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC 20052, USA.; ImmunoBlue, Bethesda, MD 20817, USA.

Publikováno v: Nano research [Nano Res] 2022 Mar; Vol. 15 (3), pp. 2300-2314. Date of Electronic Publication: 2021 Oct 12.

Zobrazit plný text záznamu

Akademický článek

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.

Autor: Powell AB; George Washington University Cancer Center, George Washington University, Washington, DC, USA., Yadavilli S; Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA., Saunders D; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Van Pelt S; George Washington University Cancer Center, George Washington University, Washington, DC, USA., Chorvinsky E; Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA., Burga RA; George Washington University Cancer Center, George Washington University, Washington, DC, USA., Albihani S; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Hanley PJ; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Xu Z; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Pei Y; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Yvon ES; George Washington University Cancer Center, George Washington University, Washington, DC, USA., Hwang EI; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA., Bollard CM; George Washington University Cancer Center, George Washington University, Washington, DC, USA.; Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA., Nazarian J; Center for Genetic Medicine Research, Children's National Medical Center, Washington, DC, USA., Cruz CRY; George Washington University Cancer Center, George Washington University, Washington, DC, USA. ccruz@childrensnational.org.; Center for Cancer and Immunology Research, Children's National Medical Center, 111 Michigan Ave. NW, Washington, DC, 20010, USA. ccruz@childrensnational.org.

Publikováno v: Journal of translational medicine [J Transl Med] 2019 Sep 23; Vol. 17 (1), pp. 321. Date of Electronic Publication: 2019 Sep 23.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.

Autor: Yvon ES; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, The University of Texas, Houston, Texas., Burga R; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA., Powell A; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA., Cruz CR; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA., Fernandes R; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA., Barese C; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA., Nguyen T; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, The University of Texas, Houston, Texas., Abdel-Baki MS; Nationwide Children's Hospital, Columbus, Ohio., Bollard CM; Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA. Electronic address: cbollard@cnmc.org.

Publikováno v: Cytotherapy [Cytotherapy] 2017 Mar; Vol. 19 (3), pp. 408-418. Date of Electronic Publication: 2017 Jan 19.

Zobrazit plný text záznamu

Akademický článek

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.

Autor: Gargett T; Translational Oncology Laboratory Centre for Cancer Biology, SA Pathology, and University of South Australia, Adelaide, South Australia. Electronic address: Tessa.Gargett@health.sa.gov.au., Yu W; Translational Oncology Laboratory Centre for Cancer Biology, SA Pathology, and University of South Australia, Adelaide, South Australia., Dotti G; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital, Feigin Center, Houston, Texas, USA; Department of Microbiology and Immunology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA., Yvon ES; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital, Feigin Center, Houston, Texas, USA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Christo SN; Experimental Therapeutics Laboratory, Sansom Institute and Hanson Institute, School of Pharmacy and Medical Science, University of South Australia, Adelaide, South Australia., Hayball JD; Experimental Therapeutics Laboratory, Sansom Institute and Hanson Institute, School of Pharmacy and Medical Science, University of South Australia, Adelaide, South Australia; Robinson Research Institute, Discipline of Obstetrics and Gynecology, School of Medicine, University of Adelaide, Adelaide, South Australia; Discipline of Medicine, University of Adelaide, Adelaide, South Australia., Lewis ID; Discipline of Medicine, University of Adelaide, Adelaide, South Australia., Brenner MK; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital, Feigin Center, Houston, Texas, USA., Brown MP; Translational Oncology Laboratory Centre for Cancer Biology, SA Pathology, and University of South Australia, Adelaide, South Australia; Discipline of Medicine, University of Adelaide, Adelaide, South Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia.

Publikováno v: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2016 Jun; Vol. 24 (6), pp. 1135-1149. Date of Electronic Publication: 2016 Mar 29.

Zobrazit plný text záznamu

Akademický článek

All-in-one processing of heterogeneous human cell grafts for gene and cell therapy.

Autor: Lukianova-Hleb EY; Department of BioSciences, Rice University , Houston, Texas, USA., Yvon ES; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA., Shpall EJ; Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center , Houston, Texas, USA., Lapotko DO; Department of BioSciences, Rice University , Houston, Texas, USA.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2016 Mar 16; Vol. 3, pp. 16012. Date of Electronic Publication: 2016 Mar 16 (Print Publication: 2016).

Zobrazit plný text záznamu

Akademický článek

Gene Modification of Human Natural Killer Cells Using a Retroviral Vector.

Autor: Kellner JN; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., P14.2920, Unit #065, Houston, TX, 77030, USA., Cruz CR; Program for Cell Enhancement and Technologies for Immunotherapy, The Sheikh Zayed Institute for Pediatric Surgical Innovation, the Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, 20052, USA.; Departments of Pediatrics and Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, 20052, USA., Bollard CM; Program for Cell Enhancement and Technologies for Immunotherapy, The Sheikh Zayed Institute for Pediatric Surgical Innovation, the Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, 20052, USA.; Departments of Pediatrics and Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, 20052, USA., Yvon ES; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., P14.2920, Unit #065, Houston, TX, 77030, USA. ESYvon@mdanderson.org.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2016; Vol. 1441, pp. 203-13.

Zobrazit plný text záznamu

Akademický článek

BRAF and MEK inhibition variably affect GD2-specific chimeric antigen receptor (CAR) T-cell function in vitro.

Autor: Gargett T; Translational Oncology Laboratory, Centre for Cancer Biology, SA Pathology, and University of South Australia §Cancer Clinical Trials Unit, Royal Adelaide Hospital ∥Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia †Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital ‡Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Fraser CK, Dotti G, Yvon ES, Brown MP

Publikováno v: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2015 Jan; Vol. 38 (1), pp. 12-23.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání